APA citiranje

Park, Y. Y., An, C. H., Oh, S. T., Chang, E. D., & Lee, J. (2019). Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma. Medicine (Baltimore).

Citação norma Chicago

Park, Youn Young, Chang Hyeok An, Seong Taek Oh, Eun Deock Chang, and Jaeim Lee. "Expression of CD133 Is Associated With Poor Prognosis in Stage II Colorectal Carcinoma." Medicine (Baltimore) 2019.

MLA citiranje

Park, Youn Young, et al. "Expression of CD133 Is Associated With Poor Prognosis in Stage II Colorectal Carcinoma." Medicine (Baltimore) 2019.